Driving innovation with QR Codes

AbbVie awarded 5th in AFR BOSS Most Innovative Health Industries List for QR code innovation

Learn more

1 December, 2020

Venclexta (venetoclax) PBS listed as first line therapy for Chronic Lymphocytic Leukaemia (CLL) patients unfit for chemotherapy

28 October, 2020

AbbVie collaborates with BioCurate to accelerate commercialisation of Australian novel early stage discoveries into new therapeutics and drugs

16 September, 2020

MAVIRET® is the first PBS listed Hepatitis C treatment available for Australians 12 years and over

By putting patients first, we explore new medical innovations and ways to enhance access

Patients

Clare’s story: Living with Rheumatoid Arthritis

AbbVie #2 Great Place to Work

All Stories

500 Milliliter Flasks on a White Background.

Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest

Our Science

$36+ million

invested by AbbVie in Australian medical research and clinical trials in 2019

Passionate about our work, responsible in our actions—we go beyond medicine to improve health care and our communities

Responsibility

A man wearing goggles stares into a tray of test tubes.

AbbVie combines advanced science, expertise and passion to solve the world’s most serious health issues and have a remarkable impact on people’s lives

Our Company

30,000+

people treated by AbbVie medicines in Australia

20+

conditions treated across infant, adolescent, adult and senior stages of life in Australia

11,000+

patients are supported via AbbVie’s patient care programs in Australia